100% Response Rate with Anti-PD1 Therapy for Patients with Lymphoma

ASHReport has 142 videos Subscribe Here

Description: Joshua Brody, MD, PhD, of Mount Sinai Hospital, gives an overview of a clinical trial by Dana Farber that shows patients with primary central nervous system lymphoma has a 100% response rate with anti-PD1 therapy at the 58th ASH Annual Meeting in San Diego, CA.
Shared By : ASHReport
Posted on : 12/09/16
Added : 12 months ago
Category : Lymphoma


Nothing found.

More From ASHReport

Nothing found.